Updated:
AJS BioTree Healthcare Fund
AJS BioTree Healthcare Fund is a family office investing across healthcare in public and private markets from offices in the US and Asia.
AJS BioTree Healthcare Fund
AJS BioTree Healthcare Fund is a family office that focuses exclusively on healthcare investments. Its founding year and principals are not publicly disclosed, but the firm maintains a significant physical footprint across the United States and Asia, with offices in Menlo Park, San Francisco, Palo Alto, San Mateo, Glendale, Tokyo, Seoul, and Gyeonggi-do. The wealth origin underlying the fund remains confidential. The strategy spans a broad healthcare mandate—encompassing biotech, pharmaceuticals, MedTech, digital health, and healthcare services—across both public and private markets. The fund pursues direct investments, co-investments, and fund commitments, allowing for flexibility in stage coverage from early-stage venture to late-stage growth and public equities. Confirmed portfolio activity includes positions in both US and Asia-based healthcare companies, though specific holdings are not publicly disclosed. Geographic deployment covers North America and Asia, particularly Japan and South Korea. The total AUM and number of professionals are not disclosed. The firm's multiple office locations suggest a lean, cross-border team structure. No philanthropic or adjacent operating vehicles have been publicly linked to the fund. Recent operational updates are unavailable, given the firm's limited public presence. AJS BioTree's structural differentiator is its concentrated healthcare-only mandate combined with a multi-continent platform that bridges US and Asian markets. This architecture enables the firm to source and execute deals in both regions simultaneously, an advantage in cross-border healthcare transactions where regulatory and market knowledge in both hemispheres is critical. The governance and succession structure are not disclosed.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
San Francisco, CA · Tokyo, Japan · Palo Alto, CA · Seoul, South Korea · Gyeonggi-do, South Korea · San Mateo, CA · Glendale, CA
Sector focus
Frequently asked questions
What investment stages does AJS BioTree Healthcare Fund typically target?
The fund appears to be stage-agnostic within healthcare, pursuing early-stage venture, growth-stage private equity, and public equities. This flexibility allows participation in opportunities from biotech startups to established pharmaceutical companies (per public record).
How does AJS BioTree Healthcare Fund source proprietary deal flow?
With offices in Menlo Park, San Francisco, Tokyo, and Seoul, the fund likely leverages its geographic presence to source deals directly from founders and corporates in both the US and Asia. The healthcare focus further narrows its network within the sector.
Is AJS BioTree structured as a single family office or a multi-family office?
Public information does not specify the structure. The multiple locations and healthcare-specific mandate could be consistent with either a large single-family office or a multi-family office serving healthcare-oriented families.
Which sectors does AJS BioTree Healthcare Fund explicitly avoid?
The firm's exclusive healthcare focus means it avoids all non-healthcare sectors including technology, energy, real estate, and consumer goods. Within healthcare, no specific subsectors are publicly identified as off-limits (per public record).
Does AJS BioTree participate in fund commitments or only direct deals?
The fund is known to make both direct investments and fund commitments across healthcare. This dual approach provides exposure to both specific companies and diversified healthcare funds (per public record).
Where does the underlying wealth come from?
The wealth origin is not publicly disclosed. The fund's Asian office locations in Japan and South Korea, alongside US offices, suggest a potential East Asian wealth base, but no confirming information is available.
How can allocators engage with AJS BioTree Healthcare Fund?
Given the lack of public contact information or a website, engagement is likely relationship-driven. Allocators may need to connect through intermediaries, co-investment partners, or industry events in the healthcare investment community.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: